J M Wright|T C Sarich - JoVE Visualize

Showing results (191-200 of 211) with videos related to

Pageof 22

Sort By:

Blood Pressure Monitoring|August 24, 2001

Validation of a new algorithm for the BPM-100 electronic oscillometric office blood pressure monitorJ M Wright, G S Mattu, T L Perry, et al.

Clinical Pharmacology and Therapeutics|August 1, 1993

Inhibition and induction of cytochrome P4502E1-catalyzed oxidation by isoniazid in humansR Zand, S D Nelson, J T Slattery, et al.

Neuroscience Letters|September 30, 1985

Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by four different antioxidants in the mouseT L Perry, V W Yong, R M Clavier, et al.

Journal of Exposure Science & Environmental Epidemiology|August 22, 2025

Birth weight in relation to maternal and neonatal biomarker concentration of perfluorooctane sulfonic acid: a meta-analysis and meta-regression from a systematic reviewJ M Wright, K M Rappazzo, H Ru, et al.

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|April 1, 1997

Prevalence of periodontal disease in patients with Sjögren's syndromeM P Najera, I al-Hashimi, J M Plemons, et al.

Neuroscience Letters|August 5, 1985

Effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, N-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouseT L Perry, V W Yong, K Jones, et al.

Neurology|April 1, 1982

A double-blind clinical trial of isoniazid in Huntington diseaseT L Perry, J M Wright, S Hansen, et al.

Journal of Neurochemistry|July 1, 1981

Elevation of brain GABA content by chronic low-dosage administration of hydrazine, a metabolite of isoniazidT L Perry, S J Kish, S Hansen, et al.

Atherosclerosis|November 2, 2024

Publication bias in pharmacogenetics of statin-associated muscle symptoms: A meta-epidemiological studyA Gougeon, I Aribi, S Guernouche, et al.

The Canadian Journal of Cardiology|March 1, 1991

Effectiveness and tolerability of once versus twice daily nitrendipine in the treatment of mild to moderate hypertension. The Canadian Nitrendipine Study GroupP Bolli, J Cobby, S P Handa, et al.

Pageof 22

Showing results (191-200 of 211) with videos related to

Sort By:

Pageof 22

Blood Pressure Monitoring|August 24, 2001

Validation of a new algorithm for the BPM-100 electronic oscillometric office blood pressure monitorJ M Wright, G S Mattu, T L Perry, et al.

Clinical Pharmacology and Therapeutics|August 1, 1993

Inhibition and induction of cytochrome P4502E1-catalyzed oxidation by isoniazid in humansR Zand, S D Nelson, J T Slattery, et al.

Neuroscience Letters|September 30, 1985

Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by four different antioxidants in the mouseT L Perry, V W Yong, R M Clavier, et al.

Journal of Exposure Science & Environmental Epidemiology|August 22, 2025

Birth weight in relation to maternal and neonatal biomarker concentration of perfluorooctane sulfonic acid: a meta-analysis and meta-regression from a systematic reviewJ M Wright, K M Rappazzo, H Ru, et al.

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|April 1, 1997

Prevalence of periodontal disease in patients with Sjögren's syndromeM P Najera, I al-Hashimi, J M Plemons, et al.

Neuroscience Letters|August 5, 1985

Effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, N-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouseT L Perry, V W Yong, K Jones, et al.

Neurology|April 1, 1982

A double-blind clinical trial of isoniazid in Huntington diseaseT L Perry, J M Wright, S Hansen, et al.

Journal of Neurochemistry|July 1, 1981

Elevation of brain GABA content by chronic low-dosage administration of hydrazine, a metabolite of isoniazidT L Perry, S J Kish, S Hansen, et al.

Atherosclerosis|November 2, 2024

Publication bias in pharmacogenetics of statin-associated muscle symptoms: A meta-epidemiological studyA Gougeon, I Aribi, S Guernouche, et al.

The Canadian Journal of Cardiology|March 1, 1991

Effectiveness and tolerability of once versus twice daily nitrendipine in the treatment of mild to moderate hypertension. The Canadian Nitrendipine Study GroupP Bolli, J Cobby, S P Handa, et al.

Pageof 22